EN HU

Csikos Csaba

Csikos Csaba

Publication list

Uploaded publications:
13
Publications in DEA:
13
OA:
10
Date range:
2021-2025
2025
1.
Ngo, M. T., Vágner, A., Nagy, G., Ország, G., Nagy, T., Szoboszlai, Z., Csikos, C., Váradi, B., Trencsényi, G., Tircsó, G., Garai, I.: HER2 expression in different cell lines at different inoculation sites assessed by [52Mn]Mn-DOTAGA(anhydride)-trastuzumab.
Pathol. Oncol. Res. 31, 1-12, (article identifier: 1611999), 2025.
Journal metrics:
Q3 Cancer Research (2024)
Q2 Medicine (miscellaneous) (2024)
Q2 Oncology (2024)
Q2 Pathology and Forensic Medicine (2024)
2.
Ngo, M. T., Nagy, T., Szoboszlai, Z., Csikos, C., Dénes, N., Furka, A., Trencsényi, G., Garai, I.: The Relationship of Metabolic Activity and αvβ3 Receptor Expression in Aggressive Breast Cancer Subtypes Tumors: a Preliminary Report.
In Vivo. 39 (1), 160-171, 2025.
Journal metrics:
Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous) (2024)
Q3 Cancer Research (2024)
Q2 Medicine (miscellaneous) (2024)
Q3 Pharmacology (2024)
2024
3.
Ngo, M. T., Vágner, A., Nagy, G., Ország, G., Nagy, T. M., Csikos, C., Váradi, B., Sajtos, G. Z., Kapus, I., Szoboszlai, Z., Szikra, D. P., Trencsényi, G., Tircsó, G., Garai, I.: [52 Mn]Mn-BPPA-Trastuzumab: A Promising HER2-Specific PET Radiotracer.
J. Med. Chem. 67 (10), 8261-8270, 2024.
Journal metrics:
D1 Drug Discovery
Q1 Molecular Medicine
4.
Csikos, C., Barna, S., Kovács, Á., Czina, P., Budai, Á., Szolikova, M., Nagy, I. G., Husztik, B., Kiszler, G., Garai, I.: AI-Based Noise-Reduction Filter for Whole-Body Planar Bone Scintigraphy Reliably Improves Low-Count Images.
Diagnostics. 14 (23), 1-11, (article identifier: 2686), 2024.
Journal metrics:
Q2 Clinical Biochemistry
Q2 Internal Medicine
5.
Barna, S., Szolikova, M., Csikos, C., Török, J., Husztik, B., Varga, J., Kovács, Á., Garai, I.: Artificial Intelligence Based CT-free Attenuation Correction in Adolescent and Young Adult Mandibular Condylar Hyperplasia Patients.
Eur. J. Nucl. Med. Mol. Imaging. 51 (Suppl.), S778-S779, 2024.
6.
Képes, Z., Hegedűs, É., Sass, T., Csikos, C., Péli-Szabó, J., Szugyiczki, V., Hajdu, I., Kertész, I., Opposits, G., Imrek, J., Balkay, L., Kálmán, F. K., Trencsényi, G.: Concomitant [18F]F-FAZA and [18F]F-FDG Imaging of Gynecological Cancer Xenografts: insight Into Tumor Hypoxia.
In Vivo. 38 (2), 574-586, 2024.
Journal metrics:
Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous)
Q3 Cancer Research
Q2 Medicine (miscellaneous)
Q3 Pharmacology
7.
Képes, Z., Arató, V. Z., Csikos, C., Hegedűs, É., Esze, R., Nagy, T., Jószai, I., Emri, M., Kertész, I., Trencsényi, G.: In Vivo Evaluation of Brain [18F]F-FDG Uptake Pattern Under Different Anaesthesia Protocols.
In Vivo. 38 (2), 587-597, 2024.
Journal metrics:
Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous)
Q3 Cancer Research
Q2 Medicine (miscellaneous)
Q3 Pharmacology
8.
Csikos, C., Czina, P., Molnár, S., Kovács, A. R., Garai, I., Krasznai, Z. T.: Predicting Complete Cytoreduction with Preoperative [18F]FDG PET/CT in Patients with Ovarian Cancer: a Systematic Review and Meta-Analysis.
Diagnostics. 14 (16), 1-14, (article identifier: 1740), 2024.
Journal metrics:
Q2 Clinical Biochemistry
Q2 Internal Medicine
9.
Trencsényi, G., Csikos, C., Képes, Z.: Targeted Radium Alpha Therapy in the Era of Nanomedicine: In Vivo Results.
Int. J. Mol. Sci. 25 (1), 1-30, (article identifier: 664), 2024.
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
Q1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
D1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
10.
Csikos, C., Barna, S., Kovács, Á., Budai, Á., Szolikova, M., Nagy, I. G., Husztik, B., Kiszler, G., Garai, I.: Validation of an AI-Based Noise Reduction Filter on Bone Scan Images.
Eur. J. Nucl. Med. Mol. Imaging. 51 (Suppl.), S787, 2024.
2023
11.
Csikos, C., Képes, Z., Fekete, A., Vágner, A., Nagy, G., Gyuricza, B., Arató, V. Z., Kárpáti, L., Mándity, I. M., Bruchertseifer, F., Halmos, G., Szikra, D. P., Trencsényi, G.: Evaluation of the therapeutic efficacy of 213Bi-labelled DOTA-conjugated alpha-melanocyte stimulating hormone peptide analogues in melanocortin-1 receptor positive preclinical melanoma model.
Int. J. Pharm. 644, 1-9, (article identifier: 123344), 2023.
Journal metrics:
Q1 Pharmaceutical Science
12.
Csikos, C., Vágner, A., Nagy, G., Kálmán-Szabó, I., Péli-Szabó, J., Ngo, M. T., Szoboszlai, Z., Szikra, D. P., Krasznai, Z. T., Trencsényi, G., Garai, I.: In Vivo Preclinical Assessment of the VEGF Targeting Potential of the Newly Synthesized [52Mn]Mn-DOTAGA-Bevacizumab Using Experimental Cervix Carcinoma Mouse Model.
Diagnostics. 13 (2), 236-, 2023.
Journal metrics:
Q2 Clinical Biochemistry
2021
13.
Kiss, A., Csikos, C., Regdon, Z., Polgár, Z., Virág, L., Hegedűs, C.: NMNAT1 Is a Survival Factor in Actinomycin D-Induced Osteosarcoma Cell Death.
Int. J. Mol. Sci. 22 (16), 1-17, (article identifier: 8869), 2021.
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
Q1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
Q1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
DEENK University of Debrecen
© 2012 University of Debrecen